Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for CareDx, Inc. (CDNA : NSDQ)
 
 • Company Description   
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.

Number of Employees: 765

 
 • Price / Volume Information   
Yesterday's Closing Price: $21.63 Daily Weekly Monthly
20 Day Moving Average: 736,812 shares
Shares Outstanding: 51.66 (millions)
Market Capitalization: $1,117.38 (millions)
Beta: 2.49
52 Week High: $23.24
52 Week Low: $10.96
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 7.83% 2.56%
12 Week 14.93% 6.25%
Year To Date 14.81% 5.26%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
8000 Marina Boulevard 4th Floor
-
Brisbane,CA 94005
USA		 ph: 415-287-2300
fax: 415-287-2450		 investor@caredx.com http://www.caredx.com
 
 • General Corporate Information   
Officers
John W. Hanna - President and Chief Executive Officer
Nathan Smith - Chief Financial Officer
Fred E. Cohen - Director
Christine M. Cournoyer - Director
Michael D. Goldberg - Director

Peer Information
CareDx, Inc. (CHCR)
CareDx, Inc. (ESRX)
CareDx, Inc. (MYDP)
CareDx, Inc. (COR)
CareDx, Inc. (GBCS)
CareDx, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 14167L103
SIC: 8071
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/05/26
Share - Related Items
Shares Outstanding: 51.66
Most Recent Split Date: (:1)
Beta: 2.49
Market Capitalization: $1,117.38 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.06 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.22 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/05/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 98.32
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 3.56
Price/Cash Flow: 3,320.85
Price / Sales: 2.71
EPS Growth
vs. Year Ago Period: 126.32%
vs. Previous Quarter: 162.50%
Sales Growth
vs. Year Ago Period: 38.99%
vs. Previous Quarter: 8.59%
ROE
03/31/26 - -2.65
12/31/25 - -6.50
09/30/25 - 20.15
ROA
03/31/26 - -1.96
12/31/25 - -4.83
09/30/25 - 15.15
Current Ratio
03/31/26 - 3.40
12/31/25 - 2.86
09/30/25 - 3.03
Quick Ratio
03/31/26 - 3.07
12/31/25 - 2.56
09/30/25 - 2.75
Operating Margin
03/31/26 - -2.01
12/31/25 - -5.65
09/30/25 - 19.65
Net Margin
03/31/26 - -2.01
12/31/25 - -5.65
09/30/25 - 19.65
Pre-Tax Margin
03/31/26 - -1.94
12/31/25 - -5.55
09/30/25 - 19.71
Book Value
03/31/26 - 6.07
12/31/25 - 5.89
09/30/25 - 6.05
Inventory Turnover
03/31/26 - 4.70
12/31/25 - 4.66
09/30/25 - 4.70
Debt-to-Equity
03/31/26 - 0.00
12/31/25 - 0.00
09/30/25 - 0.00
Debt-to-Capital
03/31/26 - 0.00
12/31/25 - 0.00
09/30/25 - 0.00
 

Powered by Zacks Investment Research ©